We Spent $425 Billion Before Discounts

We spent $425 billion that is before discounts last year on prescription drugs in United States. The overall increase of spending (up 12% from 2014) is due to a surge of new drugs being approved and becoming available for patients use.

 The drugs that saw the largest increase (20%) was specialty pharmaceuticals, including drugs to treat hepatitis C, cancer and multiple sclerosis which generated invoices worth $151 billion. Read article here…..

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.